Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Warbey · SciRah

Researcher profile · Semantic Scholar

V. Warbey

Share profile

V. Warbey — researcher profile on SciRah

h-index: 15
Works: 50
Citations: 597

Most-cited papers

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1
V. Warbey, R. Ferner, J. Dunn, E. Calonje +1 more
2009European Journal of Nuclear Medicine and Molecular Imaging147 citations
Semantic Scholar
Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era
Simon E. Richardson, J. Sudak, V. Warbey, A. Ramsay +1 more
2012Leukemia and Lymphoma47 citations
Semantic Scholar
Neuroendocrine tumors: role of interventional radiology in therapy.
M. Steward, V. Warbey, A. Malhotra, M. Caplin +2 more
2008Radiographics44 citations
Semantic Scholar
The role of new PET tracers for lung cancer
S. Kamat, T. Szyszko, M. Subesinghe, B. Fischer +3 more
2019Minerva Pneumologica40 citations Open access
Semantic Scholar
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
A. Gibb, S. Pirrie, K. Linton, V. Warbey +13 more
2020British Journal of Haematology35 citations Open access
Semantic Scholar
The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
M. Kulkarni, Simon Hughes, Andrew Mallia, V. Gibson +10 more
2019European Journal of Nuclear Medicine and Molecular Imaging30 citations Open access
Semantic Scholar
Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18F-FDG PET
G. Cook, E. Lovat, M. Siddique, V. Goh +2 more
2017European Journal of Nuclear Medicine and Molecular Imaging24 citations Open access
Semantic Scholar
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL
T. Eyre, C. Hildyard, A. Hamblin, Ayesha S Ali +17 more
2019Hematological Oncology23 citations Open access
Semantic Scholar
Interim fluoro-2-deoxy-D-glucose–PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection
J. Okosun, V. Warbey, Kate Shaw, S. Montoto +6 more
2012AIDS (London)20 citations Open access
Semantic Scholar
Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques
D. El-Sharkawi, A. Ramsay, Kate Cwynarski, D. Hughes +8 more
2011Leukemia and Lymphoma20 citations
Semantic Scholar
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma
A. Rockall, T. Barwick, W. Wilson, Naveena Singh +17 more
2021Clinical Cancer Research19 citations Open access
Semantic Scholar
The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
E. Lovat, Musib Siddique, V. Goh, R. Ferner +2 more
2017EJNMMI Research18 citations Open access
Semantic Scholar
A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
A. Afaq, H. Payne, R. Davda, J. Hines +11 more
2021Journal of Nuclear Medicine17 citations Open access
Semantic Scholar
Impact of 18F-fluciclovine positron emission tomography on the management of patients with recurrence of prostate cancer: results from the FALCON trial.
A. Scarsbrook, D. Bottomley, E. Teoh, K. Bradley +22 more
2020International Journal of Radiation Oncology, Biology, Physics16 citations Open access
Semantic Scholar
Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial
T. Georgi, L. Kurch, D. Hasenclever, V. Warbey +5 more
2020PLoS ONE15 citations Open access
Semantic Scholar
The role of 99mTc-depreotide in the management of neuroendocrine tumours
T. Shah, I. Kulakienė, A. Quigley, V. Warbey +5 more
2008Nuclear medicine communications13 citations
Semantic Scholar
The new EANM paediatric dosage card — does it conform to ALARA for PET/CT?
V. Warbey, P. Schleyer, S. Barrington, M. O'Doherty
2007European Journal of Nuclear Medicine and Molecular Imaging11 citations
Semantic Scholar
OUTCOME OF CURATIVE RADIOTHERAPY FOR LOCALISED FOLLICULAR LYMPHOMA IN THE ERA OF 18F‐FDG PET‐CT STAGING: AN INTERNATIONAL COLLABORATIVE STUDY ON BEHALF OF ILROG
J. Brady, M. Binkley, C. Hajj, M. Chelius +21 more
20179 citations Open access
Semantic Scholar
Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions
T. Georgi, L. Kurch, D. Hasenclever, V. Warbey +5 more
2023PLoS ONE8 citations Open access
Semantic Scholar
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
A. Afaq, F. Gleeson, A. Scarsbrook, K. Bradley +10 more
2019Nuclear medicine communications7 citations Open access
Semantic Scholar
PSMA PET/CT imaging for primary staging of intermediate and high‐risk prostate cancer
G. Cook, M. Kulkarni, V. Warbey
2019BJU International7 citations
Semantic Scholar
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy.
R. Goldstein, C. Stefanato, V. Warbey, M. Harries
2012Future Oncology7 citations
Semantic Scholar
Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial
E. Teoh, D. Bottomley, A. Scarsbrook, H. Payne +14 more
20176 citations
Semantic Scholar
The FALCON trial: Impact of 18F-fluciclovine PET/CT on clinical management choices for men with biochemically recurrent prostate cancer.
E. Teoh, D. Bottomley, A. Scarsbrook, H. Payne +14 more
20185 citations
Semantic Scholar
Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study
Ben King, N. Bharwani, William Wilson, Gary J. R. Cook +16 more
2025European Journal of Nuclear Medicine and Molecular Imaging3 citations Open access
Semantic Scholar
FDG PET‐CT imaging in head and neck paragangliomas: A centre experience
S. Boughdad, A. O'Connor, G. Cook, L. Pike +3 more
2021Clinical Endocrinology3 citations Open access
Semantic Scholar
Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery
Louise Stanton, Geoff N. Saunders, S. Barrans, J. Caddy +22 more
2025Blood1 citations
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
V. Radhakrishnan, L. Stanton, J. Caddy, N. Keyworth +12 more
2023Hematological Oncology1 citations Open access
Semantic Scholar
Feature based differentiation of benign, malignant and atypical neurofibroma in FDG-PET scans
Arunabha Roy, V. Warbey, R. Ferner, M. O'Doherty +1 more
20121 citations
Semantic Scholar
A22 Zevalin: First experience of 18 months of non-research use
V. Warbey, A. Quigley, M. Ng, R. Hussain +3 more
20061 citations
Semantic Scholar
Coronavirus disease 2019 (COVID‐19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial
S. Williams, Y. Lim, R. Cooper, C. Gamble +17 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
Glofitamab in refractory Burkitt lymphoma‐type post‐transplant lymphoproliferative disorder
H. Lam, Suzanne O. Arulogun, N. G. Mikhaeel, J. Brady +6 more
2026British Journal of Haematology0 citations
Semantic Scholar
ANIMATE: A PHASE II STUDY OF NIVOLUMAB IN TRANSPLANT ELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA
S. Booth, A. Kirkwood, P. Johnson, S. Barrington +12 more
2021Hematological Oncology0 citations Open access
Semantic Scholar
Interreader-Variabilität bei der Interim-PET-Bewertung beim Hodgkin Lymphom - Was sind Gründe für diskrepante Befunde?
T. Georgi, L. Kurch, D. Hasenclever, V. Warbey +5 more
2020Nuklearmedizin0 citations
Semantic Scholar
Quantitative assessment of interim PET in Hodgkin lymphoma An evaluation of the qPET method in adult patients in the RAPID trial
T. Georgi, L. Kurch, D. Hasenclever, V. Warbey +4 more
20190 citations
Semantic Scholar
Die quantitative Bewertung des Interim PET (iPET) beim Hodgkin Lymphom (HL) – Eine Re-evaluation der qPET Method anhand der RAPID Studie
T. Georgi, D. Hasenclever, L. Kurch, V. Warbey +4 more
2019Nuklearmedizin0 citations
Semantic Scholar
PO-0664: Outcome of radiotherapy for stage I and II follicular lymphoma in patients staged by 18 FDG PET-CT
J. Brady, S. Barrington, V. Warbey, N. Mikhaeel
20160 citations Open access
Semantic Scholar
Preliminary results of a phase II study of brentuximab vedotin using a response adapted design for the first line treatment of patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (BREVITY)
A. Gibb, Sarah Pirrie, K. Linton, K. Paterson +10 more
20160 citations
Semantic Scholar
Patterns of Mediastinal Lymph Node (MLN) Involvement by Lymphoma Using International Association for the Study of Lung Cancer (IASLC) Classification
G. Mikhaeel, H. Møller, V. Warbey
20140 citations
Semantic Scholar
569 THE UTILITY OF RADIOISOTOPE BONE SCANS IN LIVER TRANSPLANT ASSESSMENT FOR HCC
K. Sheikh, V. Warbey, J. O'Beirne, D. Patch +2 more
20110 citations
Semantic Scholar
From suspiciously malignant to benign: a pictorial review of FDG PET negative pulmonary lesions on PET/CT and conventional computed tomography
M. Nathan, C. Symeonidou, S. Stuart, G. Wignall +3 more
20090 citations
Semantic Scholar
P62 Clinical role of I-123/131-mIBG scintigraphy in children with neuroblastoma: A pictorial review
G. Gnanasegaran, V. Warbey, L. Biassoni
20070 citations
Semantic Scholar
Differential Uptake of Technetium-99m Methoxy-isobutyl- isonitrile in Follicular Lymphoma and Parathyroid Adenoma
J. Buscombe, A. Hilson, Makhlouf Taher, V. Warbey
20070 citations
Semantic Scholar
Encouraging results with the somatostatin analogue 90yttrium-Dota-octreotate for the treatment of metastatic neuroendocrine tumors: A series of 47 patients
C. Toumpanakis, A. Quigley, V. Warbey, R. Srirajaskanthan +3 more
20070 citations
Semantic Scholar
111In-Pentetreotide and 99mTc-MDP bone scintigraphy in the identification of bone metastasis
A. Quigley, G. Gnanasegaran, V. Warbey, M. Caplin +2 more
20060 citations
Semantic Scholar
Get through nuclear medicine for the FRCR and MRCP
V. Warbey
20050 citations
Semantic Scholar
Get through FRCR part 2A: practice papers for the modular examination
V. Warbey
20050 citations
Semantic Scholar
1 Quantitative evaluation of beta-amyloid brain PET imaging in dementia
S. Curry, Neva Patel, Sairah R. Khan, K. Nijran +161 more
0 citations
Semantic Scholar
Effect of F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
A. Scarsbrook, D. Bottomley, E. Teoh, Kevin M. Bradley +13 more
0 citations
Semantic Scholar
British Nuclear Medicine
M. Devous, Michael A. Navitsky, A. Siderowf, I. Kennedy +313 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Barrington×10
Invite
S. Barrington — researcher profile on SciRah
J. Radford×7
Invite
J. Radford — researcher profile on SciRah
A. Afaq×7
Invite
A. Afaq — researcher profile on SciRah
J. Buscombe×6
Invite
J. Buscombe — researcher profile on SciRah

×6

Invite

G. Cook — researcher profile on SciRah

A. Scarsbrook×6

Invite

A. Scarsbrook — researcher profile on SciRah

Invite

G. Cook — researcher profile on SciRah

Invite

N. Van As — researcher profile on SciRah

Invite

T. Georgi — researcher profile on SciRah

D. Hasenclever×5

Invite

D. Hasenclever — researcher profile on SciRah

Invite

L. Pike — researcher profile on SciRah

Invite

R. Ferner — researcher profile on SciRah